Literature DB >> 15513485

Neutrophils are active in total joint implant loosening.

Waldemar Wozniak1, Jacek Markuszewski, Malgorzata Wierusz-Kozlowska, Henryk Wysocki.   

Abstract

BACKGROUND: Polymorphonuclear neutrophils (PMN) are the first cells to take part in the local foreign body reaction in aseptic loosening of endoprostheses. The aim of this study was to evaluate the systemic host reaction to total joint replacement by measuring the production of nitric oxide by neutrophils before and after total joint replacement. PATIENTS AND
METHOD: Blood samples were collected from 33 patients (27 hips and 6 knees) before surgery, and 2 weeks, 2 months and 2.5-3 years after surgery. The levels of nitric oxide produced by PMN were measured by the method described by Markert et al. (1994).
RESULTS: Patients reporting pain in the region of the implant 3 years after surgery, and also patients with radiographic signs of loosening, had higher production of NO in the early period and 3 years after the implantation than those with good clinical results.
INTERPRETATION: We propose that elevated levels of nitric oxide production by PMNs may serve as a marker of total joint prosthesis loosening.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15513485     DOI: 10.1080/00016470410001402

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  2 in total

1.  Biomarkers in arthroplasty: a systematic review.

Authors:  Marty T Mertens; Jasvinder A Singh
Journal:  Open Orthop J       Date:  2011-03-16

2.  Inhibitory role of Annexin A1 in pathological bone resorption and therapeutic implications in periprosthetic osteolysis.

Authors:  Hend Alhasan; Mohamad Alaa Terkawi; Gen Matsumae; Taku Ebata; Yuan Tian; Tomohiro Shimizu; Yoshio Nishida; Shunichi Yokota; Fayna Garcia-Martin; Mahmoud M Abd Elwakil; Daisuke Takahashi; Mahmoud A Younis; Hideyoshi Harashima; Ken Kadoya; Norimasa Iwasaki
Journal:  Nat Commun       Date:  2022-07-07       Impact factor: 17.694

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.